Endothelin receptor antagonists vs placebo
Proportion of participants with improved functional class mean duration of study 16.8 weeks · pulmonary arterial hypertension
Endothelin receptor antagonists probably leads to higher proportion of participants with improved functional class mean… compared with placebo (moderate certainty).
1 finding from 1 review
- Endothelin receptor antagonists for pulmonary arterial hypertension 2021 · Cochrane Headline outcomes onlyOR 1.41 [1.16, 1.7]15 studies · 3060 participantsModerate